| Line item | 2025-10-31 FY | 2024-10-31 FY | 2023-10-31 FY | 2022-10-31 FY | 2021-10-31 FY |
|---|---|---|---|---|---|
| Revenue | $55.30B | $53.56B | $53.72B | $62.91B | $63.49B |
| Cost of Revenue | $43.90B | $41.74B | $42.21B | $50.65B | $50.07B |
| Gross Profit | $11.39B | $11.82B | $11.51B | $12.26B | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $1.60B | $1.64B | $1.58B | $1.65B | $1.91B |
| SG&A | $5.82B | $5.66B | $5.36B | $5.26B | $5.74B |
| Operating Income | $3.17B | $3.82B | $3.46B | $4.56B | $5.30B |
| Interest Expense | $430.00M | $452.00M | $548.00M | $359.00M | $254.00M |
| Tax Expense | $139.00M | $504.00M | -$326.00M | $1.19B | $1.01B |
| Net Income | $2.53B | $2.77B | $3.26B | $3.13B | $6.50B |
| EPS (basic) | 2.6700 | 2.8300 | 3.2900 | 3.0200 | 5.3800 |
| EPS (diluted) | 2.6500 | 2.8100 | 3.2600 | 2.9800 | 5.3300 |
| Shares (diluted) | $953.00M | $989.00M | $1.00B | $1.05B | $1.22B |